Actively Recruiting
Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study
Led by University Medical Centre Ljubljana · Updated on 2025-07-09
30
Participants Needed
1
Research Sites
122 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study evaluates the effect and safety of Cerebrolysin administered during early rehabilitation in patients with moderate neurological impairment after acute ischemic stroke, conducted at the Department of Vascular Neurology and Intensive Neurological Therapy, UMC Ljubljana.
CONDITIONS
Official Title
Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Able to perform the Action Research Arm Test (ARAT)
- Signed informed consent
- Both sexes, no age limit specified
- Acute ischemic stroke confirmed by imaging
- NIHSS score between 6 and 12
- No prior stroke or disability (mRS 0 before stroke)
You will not qualify if you...
- Unable to perform the Action Research Arm Test (ARAT)
- Previous stroke or disability (mRS greater than 0)
- Unable to understand instructions
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UMC Ljubljana - Department of Vascular Neurology and Intensive Neurological Therapy (KOVNINT)
Ljubljana, Slovenia, 1000
Actively Recruiting
Research Team
M
Matija Zupan, MD, PhD
CONTACT
M
Marjan Zaletel, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here